There is no evidence-based length for a BPC 157 TB 500 cycle. No human trial has tested BPC-157 and TB-500 together at any duration, and the cycle lengths quoted online come from forums, seller charts or animal study designs. How long a course runs, whether it includes breaks, and when it is reviewed are decisions a licensed provider makes for you.
Also searched as: how long to take bpc 157 and tb 500, wolverine stack cycle, bpc157 tb500 cycle length, bpc 157 and tb 500 protocol length.
Most questions about the BPC 157 TB 500 cycle are really two questions at once: how long should a course last, and do you need time off afterward. Online answers to both are confident and specific. The research behind them is not.
This guide is about the combined protocol. If you want duration for one peptide alone, see our guides on BPC-157 cycle length and TB-500 cycle length. Here we cover why the stack has no evidence-based cycle, what on/off cycling means, what a provider reviews, and what to tell them.
Want a licensed provider to set and review your protocol instead of a forum thread? Start a short online intake, reviewed asynchronously with no scheduled appointment.
See if the BPC-157 + TB-500 stack is right for youWhy there is no evidence-based BPC 157 TB 500 cycle
A cycle length is only evidence-based if someone has tested it in people, ideally against a comparison group. For this stack, nobody has.
- BPC-157 alone: a 2026 systematic review of human evidence found three small studies with 30 participants in total, all judged to be of poor methodological quality, with overall certainty rated very low.
- TB-500 alone: human data for TB-500 itself are essentially absent. Most research is on thymosin beta-4, the larger natural protein it is based on, in animals and cells. A 2026 orthopaedic review notes that TB-500 is a distinct fragment that is often conflated with full thymosin beta-4.
- The two together: the only controlled study we could find is a 2026 rat study of repaired Achilles tendons, which dosed for four weeks because that suited its experimental endpoint. The combination did not show additional benefit over either peptide alone in that model.
A 2026 primer in the American Journal of Sports Medicine put it plainly: indications, dosing, frequency and duration of treatment remain unknown for these peptides. A combined BPC 157 TB 500 cycle stacks two sets of unknowns, not one.
Where BPC 157 TB 500 cycle numbers online come from
If the research does not set a length, where do the confident numbers come from? Usually one of four places.
| Source | What it is | What it can tell you |
|---|---|---|
| Forum consensus | Repeated personal anecdotes | What people do, not what is safe or effective |
| Seller charts | Protocols posted next to a product | Nothing reliable; the seller has a reason to sell more |
| Animal study designs | Dosing windows matched to an experiment | How long researchers needed to measure an endpoint |
| Practitioner convention | Bounded courses with check-ins | A way to build in decision points, not a tested duration |
None of these is wrong to know about. None of them is a substitute for a prescriber who has read your history.
On/off cycling concepts, explained
"Cycling" usually means an on period, when the peptides are used, followed by an off period, when they are not. The vocabulary comes from anabolic steroid culture, where breaks exist to let a suppressed hormone system recover.
That rationale does not transfer cleanly. Neither BPC-157 nor TB-500 is known to suppress a hormonal axis the way steroids do, and no study has tested whether scheduled breaks change safety or outcomes for either peptide alone, or for a combined BPC 157 TB 500 cycle.
So why do some providers still use bounded courses? Two practical reasons:
- A built-in decision point. A defined course creates a scheduled moment to ask whether continuing still makes sense, instead of a prescription that quietly renews forever.
- Caution about total exposure. Long-term human safety is not established for either peptide. Limiting open-ended use is a reasonable response to that gap, not a claim that a break does something specific.
Does each peptide in a Wolverine stack cycle run for the same length?
Not necessarily. A provider may treat the two parts of a combined protocol together or adjust one separately, for example if a side effect seems linked to one. A pre-mixed vial makes that harder because changing one changes both, which we cover in our guide to the BPC-157 + TB-500 blend vs two vials.
The length of a BPC-157 + TB-500 course should come from a provider who knows your history. The stack is $133 per month, subject to medical approval by a licensed provider.
Start your provider reviewWhat a provider reviews before and during a BPC 157 TB 500 cycle
Duration is individual because the inputs are. A provider weighing the length of a course, and when to revisit it, typically considers:
- Why you want it. A defined, time-limited goal is a different clinical question from an open-ended one.
- Your health history. Both peptides are studied for angiogenesis, so people with a cancer history are commonly advised to avoid them; a provider decides. They are not for pregnancy or breastfeeding.
- Other medications and supplements, including any other peptides.
- How you are tolerating it. Reported or theorised side effects include injection-site reactions, headache, nausea, dizziness, fatigue and flushing.
- Anti-doping status. Both are on the WADA Prohibited List at all times.
- Whether continuing still makes sense at each review point.
There is no evidence-based timeline for when anything should be noticed, so a review point is a check-in, not a deadline for results.
What to tell your provider about a BPC 157 and TB 500 cycle
Your provider can only work with what you share. Before and during a course, be ready to tell them:
- Any previous use of BPC-157, TB-500 or a Wolverine blend, including grey-market "research use only" vials, and how long you used them.
- What you are hoping for, in your own words, so the provider can judge whether a course makes sense at all.
- Your full medical history, especially any cancer, current or past, and any plans for pregnancy.
- Everything else you take, including prescriptions, supplements and other peptides.
- Any symptoms since starting, even ones that seem minor, through secure messaging rather than waiting.
- Whether you are drug tested for sport or work.
Good questions to ask back: what is the initial course, when will it be reviewed, what would make you stop or pause it, and what should I report straight away?
Why open-ended stacking is not something to self-direct
The real question behind "how long" is often "can I just stay on it." No study, registry or trial has measured what happens over months or years of using BPC-157 and TB-500 together. Absence of reported harm is not demonstrated safety. Without scheduled reassessment, nobody is checking whether continuing still makes sense. Our guide to Wolverine stack side effects covers what is and is not documented, and BPC-157 side effects covers the single peptide.
Regulation and sport
BPC-157 is not FDA-approved, and TB-500 is not FDA-approved, for any use. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding both to the list of bulk substances that can be used in compounding (8 for, 6 against, 1 abstention), pending FDA rulemaking. The vote is advisory and non-binding; it does not change how long anyone should use either peptide. On October 28, 2026, HHS announced an interim enforcement discretion policy under which it does not intend to take enforcement action against state-licensed pharmacies that compound either peptide with a valid prescription, under strict conditions. It covers each one only as a single-ingredient product, so a BPC-157 and TB-500 blend in one vial is outside it. The telos rx stack is supplied as two separate vials, so neither vial is a blend. It is temporary while FDA decides through rulemaking, and it is not FDA approval. More detail is in our TB-500 regulatory status update. Tested athletes should read our WADA status guide: for them, the appropriate BPC 157 TB 500 cycle length is none.
How the BPC-157 + TB-500 stack works at telos rx
telos rx prescribes the BPC-157 + TB-500 stack as two separate single-ingredient compounded vials, one of BPC-157 and one of TB-500, each for subcutaneous injection, under one plan with dose, schedule and course length set by your provider. telos rx does not offer TB-500 on its own, and does not publish a house cycle length, because that would put a marketing decision in place of a clinical one.
- An online intake, reviewed asynchronously by a US-licensed provider, with no scheduled appointment.
- A prescription is required, and every plan is subject to medical approval by a licensed provider.
- Compounded by a licensed US pharmacy, with secure messaging to your care team.
- Plans can be paused or cancelled. The stack is $133 per month; see the BPC-157 + TB-500 page.
If you are curious how providers think about amounts rather than duration, see our guide to how much BPC-157 and TB-500 to take. You can also review the stack details before starting.
Let a licensed provider decide whether the BPC-157 + TB-500 stack fits you, how long a course should run, and when to review it.
See if the BPC-157 + TB-500 stack is right for youFrequently asked questions
How long is a BPC 157 TB 500 cycle?
There is no evidence-based length for a BPC 157 TB 500 cycle. No human trial has tested the combination at any duration, and a 2026 sports medicine review described dosing, frequency and duration for these peptides as unknown. A licensed provider sets the length of a course for each patient and decides when to review it.
How long to take BPC 157 and TB 500 together?
Only a prescriber who has reviewed your health history can answer that for you. Numbers that circulate online come from forums, seller charts or animal study designs, not from controlled human research. Ask your provider what the initial course is and when it will be reassessed.
Do you need to cycle off a BPC 157 TB 500 cycle?
The idea of fixed off-periods comes from anabolic steroid use, where breaks let a suppressed hormone system recover. Neither BPC-157 nor TB-500 is known to work that way, and no study has tested whether breaks change safety or outcomes. Some providers still use bounded courses so there is a planned point to stop and reassess.
What is a Wolverine stack cycle?
Wolverine stack cycle is a nickname for a course of BPC-157 and TB-500 used together. The term does not describe a standard length, dose or schedule. Any protocol should be individual and set by a licensed provider.
Is the bpc157 tb500 cycle length the same as for BPC-157 alone?
Not necessarily. A combined protocol involves two compounds with different evidence bases, and human data for TB-500 are essentially absent. A provider may weigh the two parts differently, which is why single-peptide guidance does not simply transfer to the stack.
Is the BPC-157 and TB-500 stack FDA-approved?
No. BPC-157 is not FDA-approved and TB-500 is not FDA-approved for any use. In July 2026 an FDA advisory committee voted to recommend adding both to the list of bulk substances that can be used in compounding, pending FDA rulemaking. Since October 28, 2026, an interim HHS enforcement discretion policy covers each as a single-ingredient compounded product under strict conditions, but that is temporary and is not FDA approval.
Can athletes run a BPC 157 and TB 500 cycle?
Not if they are subject to drug testing. Both peptides are on the WADA Prohibited List at all times, in and out of competition, so for a tested athlete the appropriate cycle length is none.
This article is for general education and is not medical advice, a protocol or a recommended cycle. BPC-157 and TB-500 are not FDA-approved for any use. Compounded medications are not FDA-approved. All prescriptions are subject to medical approval by a licensed provider; approval is not guaranteed. Both peptides are prohibited in sport by WADA. Individual experiences vary. telos rx is an online-first, asynchronous telehealth service.